RecruitingPhase 2NCT06388564
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Incyte Corporation
- Principal Investigator
- Incyte Medical MonitorIncyte Corporation
- Intervention
- Axatilimab(drug)
- Enrollment
- 120 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2024 – 2029
Study locations (30)
- Mayo Clinic Hospital, Phoenix, Arizona, United States
- City of Hope Medical Center, Duarte, California, United States
- University of California-Los Angeles Medl Cntr-Oncology Center Bowyer Clinic, Los Angeles, California, United States
- Stanford Cancer Center, Stanford, California, United States
- University of Colorado Cancer Center, Aurora, Colorado, United States
- Colorado Blood Cancer Institute, Denver, Colorado, United States
- Smilow Cancer Center-Yale, New Haven, Connecticut, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- The University of Chicago Medicine, Chicago, Illinois, United States
- University of Maryland-Greenebaum Cancer Center, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Washington University, St Louis, Missouri, United States
- Fred and Pamela Buffett Cancer Center, Omaha, Nebraska, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06388564 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo